QL1706 Combined With Lenvatinib and GEMOX as First - Line Treatment for Unresectable Biliary Tract Tumors
Clinical trial NCT06892925 · RECRUITING
Trial details
- NCT number
- NCT06892925
- Sponsor
- Eastern Hepatobiliary Surgery Hospital
- Status
- RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2025-06-14
- Primary completion
- 2026-04-01
- Enrollment
- 59
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.